InvestorsHub Logo
Followers 10
Posts 651
Boards Moderated 0
Alias Born 04/09/2014

Re: None

Thursday, 12/22/2016 6:24:55 AM

Thursday, December 22, 2016 6:24:55 AM

Post# of 2118
Albireo now expects to plan the path for a final "pivotal trial" with the US health authority FDA in the first quarter of 2017, on the basis of which an authorization application for the drug could be submitted